Beijing Hotgen Biotech Co Ltd Cash Flow Quality Index
Beijing Hotgen Biotech Co Ltd cash flow quality index. Beijing Hotgen Biotech Co Ltd (688068) has a Cash Flow Quality Index of -1.95x as of September 2024. Operating cash flow of CN¥-5.53 Million is below net income of CN¥2.83 Million, suggesting accrual-heavy earnings not yet converted to cash. See Beijing Hotgen Biotech Co Ltd (688068) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Beijing Hotgen Biotech Co Ltd (2016–2023)
Cash flow quality index of Beijing Hotgen Biotech Co Ltd from 2016 to 2023. Historical Cash Flow Quality Index for Beijing Hotgen Biotech Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Beijing Hotgen Biotech Co Ltd to assess how comfortably operating cash covers total debt obligations.
Beijing Hotgen Biotech Co Ltd Cash Flow Quality Index by Year (2016–2023)
Beijing Hotgen Biotech Co Ltd cash flow quality index by year from 2016 to 2023. Year-by-year earnings quality comparison for Beijing Hotgen Biotech Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Beijing Hotgen Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.69x | CN¥-25.39 Million | CN¥15.05 Million | ▼ -259.4% |
| 2022 | 1.06x | CN¥978.75 Million | CN¥925.12 Million | ▼ -11.9% |
| 2021 | 1.20x | CN¥2.64 Billion | CN¥2.20 Billion | ▼ -18.8% |
| 2020 | 1.48x | CN¥164.62 Million | CN¥111.30 Million | ▲ +157.7% |
| 2019 | 0.57x | CN¥19.37 Million | CN¥33.75 Million | ▼ -49.7% |
| 2018 | 1.14x | CN¥55.04 Million | CN¥48.19 Million | ▲ +49.7% |
| 2017 | 0.76x | CN¥22.95 Million | CN¥30.07 Million | ▼ -51.7% |
| 2016 | 1.58x | CN¥45.54 Million | CN¥28.80 Million | — |